Fatoumatta Darboe

Fatoumatta Darboe

Postdoctoral Researcher

MRC Unit The Gambia

Tel: +220 7075496 

Email: fdarboe@mrc.gm 

 

 

 

VALIDATE Role:

Network Associate

 

Research Keywords: 

TB, Biomarkers, HIV

 

Key Publications:

Fatoumatta Darboe, Mbandi S Kimbung, Kogieleum Naidoo et al. Detection of Tuberculosis recurrence, Diagnosis and Treatment response by a blood transcriptomic signature in HIVinfected persons on antiretroviral therapy. Frontiers in Microbiology, June 2019, 10; doi:10.3389/fmicb.2019.01441

Roshni Roy Chowdhury, Francesco Vallania, Cesar Joel Lopez Angel et al. A multi-cohort study of the immune factors associated with M tuberculosis infection outcomes. Nature 560, 7720, 664648 (2018), doi:10.1038/s41586-018-0439-x

Fatoumatta Darboe, Mbandi S Kimbung, Ethan Thompson et al. Tuberculosis (Edinb). 2018 Jan;108:124-126. doi:10.1016/j.tube.2017.11.001.  

Fatoumatta Darboe, Jane U Adetifa, John Reynolds et al. Frontiers in immunology 2017 Sep 8;8:1092. doi: 10.3389/fimmu.2017.01092.  

Thomas J. Scriba, Adam Penn-Nicholson, Smitha Shankar et al. Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease. Plos pathogens, 13 (11):e1006687 https://doi.org/10.1371/journal. ppat.1006687

Patrizia Amelio, Damien Portevin, Klaus Reither et al. Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell Responses in Patients with Active Pulmonary Tuberculosis from Tanzania. Plos Negl Trop Dis. 2017 Jul 31;11(7):e0005817. doi: 10.1371/journal.pntd.0005817.  

Suraj P. Parihar, Mumin Ozturk, Mohlopheni J. Marakalala et al. Protein Kinase C-delta (PKCδ), a marker of inflammation and tuberculosis disease progression in humans, is important for optimal macrophage killing effector functions and survival in mice. Mucosal Immunology, 2017 Aug 23. doi: 10.1038/mi.2017.68.  

Fletcher HA, Snowden MA, Landry B, Rida W et al. T-cell activation is an immune correlate of risk in BCG vaccinated infants. Nat Commun. 2016 Apr 12;7:11290. doi: 10.1038/ncomms11290.

Muhammed O. Afolabi, Jorjoh Ndure, Abdoulie Drammeh et al. A Phase I Randomized Clinical Trial of Candidate Human Immunodeficiency Virus type 1 Vaccine MVA.HIVA Administered to Gambian Infants. PloS one, 8(10), e78289. doi:10.1371/journal.pone.0078289

Alba Llibre, Nicole Bilek, Vincent Bondet, et al. Plasma Type I IFN protein concentrations in human tuberculosis (manuscript under review).